These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 527278)

  • 41. Urinary fibrin (-ogen) degradation products in Russell's viper (Daboia russelii siamensis) bite victims.
    Han KE; Than T; Lwin M; Swe TN; Pe T
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):198-201. PubMed ID: 8362297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Urinary cross-linked FDP in various renal diseases].
    Inuma H
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary fibrin split products in lupus nephritis.
    Zizic TM; Cwazka WF; Young NS; Stevens MB
    J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of clinical and laboratory parameters in patients with end-stage renal failure in the outcome of chronic glomerulonephritis and patients with end-stage renal failure in the outcome of other diseases.
    Popova JA; Yadrihinskaya VN; Krylova MI; Sleptsovа SS; Borisovа NV
    Wiad Lek; 2016; 69(6):739-741. PubMed ID: 28214807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Features of lipid peroxidation in the blood of patients with chronic glomerulonephritis at the stage of renal dysfunction in the presence of nephrotic syndrome].
    Tugusheva FA; Kulikova AI; Zubina IM
    Vopr Med Khim; 1993; 39(3):18-21. PubMed ID: 8333180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical significance of nitric oxide levels in patients with chronic glomerulonephritis].
    Barbarash OL; Pavlova VIu; Chesnokova IuL; Bazdyrev ED; Malyshev IIu; Manukhina EB
    Klin Med (Mosk); 2007; 85(5):57-61. PubMed ID: 17665607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of tubular interstitial changes in the genesis of the rapid progression of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Shumakov VI
    Urol Nefrol (Mosk); 1995; (3):7-9. PubMed ID: 7618227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mechanism of renal vein thrombosis in patients with nephrotic syndrome: a prospective study].
    Cheng H
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):416-9, 447. PubMed ID: 1330232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of fibrin degradation products in renal diseases in children].
    Mancini AF; Rosito P; Mei V; Tazzari R
    Minerva Pediatr; 1977 Apr; 29(15):1047-54. PubMed ID: 875983
    [No Abstract]   [Full Text] [Related]  

  • 50. [Fibrin and fibrinogen degradation products (FDP) in renal diseases. II. Serum and urinary FDP in different morphological forms of glomerulonephritis].
    Ratajczak T; Rabczyński J; Szewczyk Z
    Pol Arch Med Wewn; 1978 Apr; 59(4):429-40. PubMed ID: 662758
    [No Abstract]   [Full Text] [Related]  

  • 51. [Soluble fibrin is not excreted in urine and its plasma level is elevated in nephrotic syndrome].
    Morikawa T; Yamashiro Y; Okano K; Kasamatsu M; Sugai H; Kitamura H; Ohba I; Hotta O; Taguma Y; Sakurai J; Kitamoto Y
    Rinsho Byori; 2009 Apr; 57(4):319-23. PubMed ID: 19489432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
    Kamitsuji H; Matsunaga K; Taira K; Nakajima M; Whitworth JA; Kincaid-Smith P
    Clin Nephrol; 1988 Mar; 29(3):124-8. PubMed ID: 3359703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.
    Vermeulen M; van Vliet HH; Lindsay KW; Hijdra A; van Gijn J
    J Neurosurg; 1985 Oct; 63(4):573-7. PubMed ID: 3897478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of several parameters of hemostasis in Masugi's rabbit nephritis].
    Lagrue G; Levent M; Gouault-Heilmann M; Hirbec G; Branellec A
    Pathol Biol (Paris); 1975 Feb; 23(2):139-44. PubMed ID: 1093104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma D dimer: a useful marker of fibrin breakdown in renal failure.
    Gordge MP; Faint RW; Rylance PB; Ireland H; Lane DA; Neild GH
    Thromb Haemost; 1989 Jun; 61(3):522-5. PubMed ID: 2799764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
    Erlich JH; Holdsworth SR; Tipping PG
    Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Fibrinogen degradatiopnroducts in the serum and urine in chronic nephritis].
    Kutyrina IM; Muzychenko LI; Nevraeva OG; Kriachko AA; Tareeva IE
    Sov Med; 1978 Oct; (10):68-75. PubMed ID: 715539
    [No Abstract]   [Full Text] [Related]  

  • 60. [Fibrin and fibrinogen degradation products in renal diseases. I. FDP in blood and urine in various stages of clinical glomerulonephritis].
    Ratajczak T; Szewczyk Z; Melcer H
    Pol Arch Med Wewn; 1977 Nov; 58(5):481-92. PubMed ID: 600826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.